141 related articles for article (PubMed ID: 33131119)
1. Impact of cancer therapy on post-treatment ejaculation disorder and sexual life in testicular cancer survivors.
Koyama J; Yamashita S; Yamada S; Fujii S; Goto T; Katayama H; Satake Y; Sato T; Shimada S; Kawasaki Y; Kawamorita N; Mitsuzuka K; Arai Y; Ito A
Int J Urol; 2021 Jan; 28(1):69-74. PubMed ID: 33131119
[TBL] [Abstract][Full Text] [Related]
2. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders.
Dimitropoulos K; Karatzas A; Papandreou C; Daliani D; Zachos I; Pisters LL; Tzortzis V
Andrologia; 2016 May; 48(4):425-30. PubMed ID: 26268684
[TBL] [Abstract][Full Text] [Related]
3. Sexual function after bilateral retroperitoneal lymph node dissection for nonseminomatous testicular cancer.
Nijman JM; Schraffordt Koops H; Oldhoff J; Kremer J; Jager S
Arch Androl; 1987; 18(3):255-67. PubMed ID: 3675073
[TBL] [Abstract][Full Text] [Related]
4. Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study.
Koyama J; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Nishiyama H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2023 Nov; 30(11):1044-1050. PubMed ID: 37522577
[TBL] [Abstract][Full Text] [Related]
5. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
[TBL] [Abstract][Full Text] [Related]
6. Chronic pain has a negative impact on sexuality in testis cancer survivors.
Pühse G; Wachsmuth JU; Kemper S; Husstedt IW; Evers S; Kliesch S
J Androl; 2012; 33(5):886-93. PubMed ID: 21474790
[TBL] [Abstract][Full Text] [Related]
7. Preservation of ejaculation through a modified retroperitoneal lymph node dissection in low stage testis cancer.
Doerr A; Skinner EC; Skinner DG
J Urol; 1993 Jun; 149(6):1472-4. PubMed ID: 8388961
[TBL] [Abstract][Full Text] [Related]
8. Use of limited retroperitoneal lymphadenectomy in nonseminomatous germ cell tumors.
Sherlag AP; O'Brien DP; Graham SD
Urology; 1989 May; 33(5):355-7. PubMed ID: 2540584
[TBL] [Abstract][Full Text] [Related]
9. Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy.
Nonomura N; Nishimura K; Takaha N; Inoue H; Nomoto T; Mizutani Y; Nakao M; Okuyama A; Miki T
Int J Urol; 2002 Oct; 9(10):539-44. PubMed ID: 12445231
[TBL] [Abstract][Full Text] [Related]
10. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
11. The treatment of ejaculation disorders after retroperitoneal lymph node dissection.
Nijman JM; Jager S; Boer PW; Kremer J; Oldhoff J; Koops HS
Cancer; 1982 Dec; 50(12):2967-71. PubMed ID: 7139590
[TBL] [Abstract][Full Text] [Related]
12. Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection.
Beck SD; Bey AL; Bihrle R; Foster RS
J Urol; 2010 Nov; 184(5):2078-80. PubMed ID: 20850817
[TBL] [Abstract][Full Text] [Related]
13. Sexual functioning after multimodality treatment for disseminated nonseminomatous testicular germ cell tumor.
van Basten JP; Jonker-Pool G; van Driel MF; Sleijfer DT; Droste JH; van de Wiel HB; Schraffordt Koops H; Molenaar WM; Hoekstra HJ
J Urol; 1997 Oct; 158(4):1411-6. PubMed ID: 9302133
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
[TBL] [Abstract][Full Text] [Related]
15. [Erection and ejaculation disorders following retroperitoneal lymphadenectomy in non-seminomatous testicular tumors].
Porst H; Altwein JE; Mayer R; Bach D
Urologe A; 1984 Nov; 23(6):324-8. PubMed ID: 6542708
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
Nakamura T; Oishi M; Ueda T; Fujihara A; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Urol; 2015 Jul; 22(7):663-8. PubMed ID: 25847721
[TBL] [Abstract][Full Text] [Related]
17. Ejaculatory dysfunction after retroperitoneal lymphadenectomy.
Jones DR; Norman AR; Horwich A; Hendry WF
Eur Urol; 1993; 23(1):169-71. PubMed ID: 8386645
[TBL] [Abstract][Full Text] [Related]
18. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
[TBL] [Abstract][Full Text] [Related]
19. Sperm parameters and ejaculation before and after operative treatment of patients with germ-cell testicular cancer.
Fritz K; Weissbach L
Fertil Steril; 1985 Mar; 43(3):451-4. PubMed ID: 2984053
[TBL] [Abstract][Full Text] [Related]
20. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
